Overview

Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery

Status:
Terminated
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
To determine whether ranibizumab therapy before and after tube insertion for glaucoma surgeries can maintain the patency of the tube and prevent scar formation, and increase the chances for a successful procedure compared to observation.
Phase:
N/A
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
Genentech, Inc.
Treatments:
Ranibizumab